In the third of the 2023 ABCD webinar series, please join Professor Paul Cockwell to discuss management of chronic kidney disease in patients with type 2 diabetes.
The development of chronic kidney disease in type 2 diabetes has a profound impact on outcomes, with an incremental increase in cardiovascular disease and other clinical events and overall mortality risk. As CKD may affect up to 50% of individuals with type 2 diabetes, clinicians should have a detailed understanding of the identification, monitoring, management, and specialist referral triggers. New therapies and new approaches to risk stratification have led to a paradigm shift this area, however most patients with diabetes and CKD are not being managed to the evidence, with major implications for their long-term outcome.
This seminar will address the following areas: identification and monitoring of CKD; primary prevention including blood pressure management; optimisation of RAS inhibition; use of SGLT2 inhibitors; mineralocorticoid blockade; other therapeutic interventions with an evidence base; referral thresholds to nephrology; patient information.
Q& A will follow this presentation.
RCP Accreditation has been sought for this webinar. Certificates of attendance will be issued to those who attend the live webinar.
This webinar has been instigated and organised by ABCD. The support from our corporate sponsors has allowed us to provide this valuable educational meeting free of charge to all delegates. Sponsors have had no input into the agenda or the selection of speakers.